Product References — Mouse Balb C Serum

Low-Dose Self-Amplifying mRNA COVID-19 Vaccine Drives Strong Protective Immunity in Non-Human Primates Against SARS-CoV-2 Infection

Posted by Adam Awdish on

Low-Dose Self-Amplifying mRNA COVID-19 Vaccine Drives Strong Protective Immunity in Non-Human Primates Against SARS-CoV-2 Infection

Innovative Grade US Origin Monkey Rhesus Serum and Innovative Grade US Origin Mouse Balb C Serum from Innovative Research were used in the following study:   Low-Dose Self-Amplifying mRNA COVID-19 Vaccine Drives Strong Protective Immunity in Non-Human Primates Against SARS-CoV-2 Infection Amy R. Rappaport, Sue-Jean Hong, Ciaran D. Scallan, Leonid Gitlin, Arvin Akoopie, Gregory R. Boucher, Milana Egorova, J. Aaron Espinosa, Mario Fidanza, Melissa A. Kachura, Annie Shen, Gloria Sivko, Anne Van Abbema, Robert L. Veres & Karin Jooss Nature Communications June 7, 2022 As COVID-19 continues to be a global problem, people that were previously vaccinated or infected are getting...

Read more →

Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium

Posted by Adam Awdish on

Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium

Innovative Grade US Origin Mouse Balb C Serum from Innovative Research was used in the following study:   Isolation of Borrelia miyamotoi and Other Borreliae Using a Modified BSK Medium Adam J. Replogle, Christopher Sexton, John Young, Luke C. Kingry, Martin E. Schriefer, Marc Dolan, Tammi L. Johnson, Neeta P. Connally, Kerry A. Padgett & Jeannine M. Petersen Scientific Reports January 21, 2021 When looking for proof of bacterial infection in a patient, primary culture recovery is the most common procedure to confirm an infection. Despite the rise in the number of infections over the last decade and the identification of...

Read more →

Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy

Posted by Leanne Kodsmann on

Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy

Mouse Serum from Innovative Research was used in the following study:   Mutual Regulation of TLR/NLR and CEACAM1 in the Intestinal Microvasculature: Implications for IBD Pathogenesis and Therapy Anja Schirbel, MD, Nancy Rebert, Tammy Sadler, MS, Gail West, Florian Rieder, MD, PhD, Christoph Wagener, MD, Andrea Horst, PhD, Andreas Sturm, MD, Carol de la Motte, PhD, Claudio Fiocchi, MD IBD: Inflammatory Bowel DiseasesOctober 2018 (Volume 25, Issue 2, February 2019) "... Aortas from 8–12-week-old Balb C mice were harvested and cultured in 3-dimensional collagen gels as previously described .... Aortic rings were dropped and positioned into wells of a 48-well...

Read more →

Balb C Mouse Serum Reference 5-25-10

Posted by Leanne Kodsman on

Innovative Research's Balb C Mouse Serum was recently used in the following study: Functional basis for complement evasion by staphylococcal superantigen-like 7J Bestebroer, PC Aerts, SHM Rooijakkers... - Cellular ..., 2010 - Wiley Online Library...Haemolysis assay. In the classical pathway haemolytic assay, NHS and BALB/c mouse serum (NMS, Innovative Research, Novi, MI, USA) were first incubated with sheep or rabbit erythrocytes, respectively, to pre-clear serum of antibodies directed against erythrocytes.

Read more →

Balb C Mouse Serum Reference 10-22-11

Posted by Leanne Kodsman on

Innovative Research's Balb C Mouse Serum was recently used in the following study: Serum inhibits the immunosuppressive function of myeloid-derived suppressor cells isolated from 4T1 tumor-bearing miceMJ Hamilton, JP Banth, V Lam, NE LePard... - Cancer Immunology, ..., 2011 - Springer...Sigma- Aldrich (St. Louis, MO) and Roche (Laval, QC, Canada). Balb c mouse serum was purchased from Innovative Research (Novi, Michigan) or harvested by cardiac puncture from naive BALB/c mice. Soluble anti-CD3...

Read more →


×